Calcitonin Gene‐Related Peptide Modulators – The History and Renaissance of a New Migraine Drug Class
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Calcitonin Gene‐Related Peptide Modulators – The History and Renaissance of a New Migraine Drug Class
Authors
Keywords
-
Journal
HEADACHE
Volume 59, Issue 6, Pages 951-970
Publisher
Wiley
Online
2019-04-25
DOI
10.1111/head.13510
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications
- (2019) David W Dodick CEPHALALGIA
- Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase Activating Peptide
- (2019) Cristina Moldovan Loomis et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
- (2018) Messoud Ashina et al. CEPHALALGIA
- Circulating Biomarkers In Migraine. New Opportunities For Precision Medicine
- (2018) Patrizia Ferroni et al. CURRENT MEDICINAL CHEMISTRY
- Erenumab: First Global Approval
- (2018) Anthony Markham DRUGS
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina
- (2018) Christophe Depre et al. HEADACHE
- CGRP as the target of new migraine therapies — successful translation from bench to clinic
- (2018) Lars Edvinsson et al. Nature Reviews Neurology
- The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy
- (2018) Bianca Raffaelli et al. Neurotherapeutics
- Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks
- (2018) Anne Luise H. Vollesen et al. JAMA Neurology
- Qualitative Change in Migraine Prevention?
- (2018) Roger Cady et al. HEADACHE
- History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment
- (2018) Stewart J. Tepper HEADACHE
- PACAP38 and PAC1 receptor blockade: a new target for headache?
- (2018) Eloisa Rubio-Beltrán et al. JOURNAL OF HEADACHE AND PAIN
- From LBR-101 to Fremanezumab for Migraine
- (2018) Marcelo E. Bigal et al. CNS DRUGS
- Galcanezumab: First Global Approval
- (2018) Yvette N. Lamb DRUGS
- The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post-Hoc Analyses on the First 3 Weeks of Treatment
- (2018) Stephen D. Silberstein et al. HEADACHE
- Anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018
- (2018) Stewart J. Tepper HEADACHE
- New Insights into the Regulation of CGRP-Family Receptors
- (2018) Joseph J. Gingell et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Lasmiditan for the treatment of migraine
- (2017) Matilde Capi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine
- (2017) Bianca Raffaelli et al. EXPERT OPINION ON PHARMACOTHERAPY
- Amylin
- (2017) Debbie L. Hay HEADACHE
- CGRP and its receptors
- (2017) Debbie L. Hay et al. HEADACHE
- An update on migraine: current understanding and future directions
- (2017) Francesca Puledda et al. JOURNAL OF NEUROLOGY
- Fremanezumab - a humanized monoclonal anti-CGRP antibody — inhibits thinly myelinated (Aδ) but not unmyelinated (C) meningeal nociceptors
- (2017) Agustin Melo-Carrillo et al. JOURNAL OF NEUROSCIENCE
- Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody
- (2017) Agustin Melo-Carrillo et al. JOURNAL OF NEUROSCIENCE
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- Erenumab (AMG 334) in episodic migraine
- (2017) Messoud Ashina et al. NEUROLOGY
- Anti-CGRP antibodies block CGRP-induced diarrhea in mice
- (2017) Eric A. Kaiser et al. NEUROPEPTIDES
- The role of calcitonin gene–related peptide in peripheral and central pain mechanisms including migraine
- (2017) Smriti Iyengar et al. PAIN
- Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects
- (2017) Thuy Vu et al. PHARMACEUTICAL RESEARCH
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers
- (2017) David Monteith et al. Frontiers in Pharmacology
- Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles
- (2016) Debbie L. Hay et al. Annual Review of Pharmacology and Toxicology
- Receptor activity-modifying proteins; multifunctional G protein-coupled receptor accessory proteins
- (2016) Debbie L. Hay et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development
- (2016) Rebekah L Bower et al. BRITISH JOURNAL OF PHARMACOLOGY
- Migraine biomarkers in cerebrospinal fluid: A systematic review and meta-analysis
- (2016) Robin M van Dongen et al. CEPHALALGIA
- A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
- (2016) Tiffini Voss et al. CEPHALALGIA
- A shot at migraine
- (2016) E. Underwood SCIENCE
- Wiping Out CGRP: Potential Cardiovascular Risks
- (2016) Antoinette MaassenVanDenBrink et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Erratum: An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology
- (2016) Joseph J Gingell et al. Cell Discovery
- Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood–brain barrier
- (2015) Sajedeh Eftekhari et al. BRAIN RESEARCH
- Development of anti-migraine therapeutics using the capsaicin-induced dermal blood flow model
- (2015) Linde Buntinx et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Telcagepant—almost gone, but not to be forgotten (invited editorial related to Ho et al., 2015)
- (2015) P Christopher H Gottschalk CEPHALALGIA
- Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine
- (2015) Tony W Ho et al. CEPHALALGIA
- Localization of CGRP receptor components and receptor binding sites in rhesus monkey brainstem: A detailed study using in situ hybridization, immunofluorescence, and autoradiography
- (2015) Sajedeh Eftekhari et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor
- (2015) Jason M. Booe et al. MOLECULAR CELL
- The novel CGRP receptor antagonist BIBN4096BS alleviates a postoperative intestinal inflammation and prevents postoperative ileus
- (2015) T. R. Glowka et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Incretins and Amylin: Neuroendocrine Communication Between the Gut, Pancreas, and Brain in Control of Food Intake and Blood Glucose
- (2014) Matthew R. Hayes et al. Annual Review of Nutrition
- Efficacy of BMS-927711 and other gepants vs triptans: There seem to be other players besides CGRP
- (2014) Julio Pascual CEPHALALGIA
- Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP
- (2014) Marcelo E Bigal et al. CEPHALALGIA
- Brain peptides and the modulation of postoperative gastric ileus
- (2014) Andreas Stengel et al. CURRENT OPINION IN PHARMACOLOGY
- Calcitonin Gene-Related Peptide Receptor Antagonists: New Therapeutic Agents for Migraine
- (2014) Ian M. Bell JOURNAL OF MEDICINAL CHEMISTRY
- Evaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptide
- (2014) Sarah Walter et al. mAbs
- Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
- (2014) T. W. Ho et al. NEUROLOGY
- De-risking the effect of CGRP receptor antagonists on coronary blood flow and systemic hemodynamics in nonhuman primates
- (2014) Christopher Regan et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Lack of hemodynamic interaction between CGRP-receptor antagonist telcagepant (MK-0974) and sumatriptan: Results from a randomized study in patients with migraine
- (2013) M Depré et al. CEPHALALGIA
- BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
- (2013) Ronald Marcus et al. CEPHALALGIA
- Gastric stasis in migraineurs: Etiology, characteristics, and clinical and therapeutic implications
- (2013) Sheena K Aurora et al. CEPHALALGIA
- Differentiation of Nerve Fibers Storing CGRP and CGRP Receptors in the Peripheral Trigeminovascular System
- (2013) Sajedeh Eftekhari et al. JOURNAL OF PAIN
- [11C]MK-4232: The First Positron Emission Tomography Tracer for the Calcitonin Gene-Related Peptide Receptor
- (2013) Ian M. Bell et al. ACS Medicinal Chemistry Letters
- Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level
- (2012) Sajedeh Eftekhari et al. BMC NEUROSCIENCE
- Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine
- (2012) Eric L Moore et al. BRITISH JOURNAL OF PHARMACOLOGY
- Primary trigeminal afferents are the main source for stimulus-induced CGRP release into jugular vein blood and CSF
- (2012) Jan Hoffmann et al. CEPHALALGIA
- A Randomized, Placebo-Controlled Study of the Effects of Telcagepant on Exercise Time in Patients With Stable Angina
- (2012) B R Chaitman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease
- (2012) Tony W. Ho et al. HEADACHE
- Brainstem sensing of meal-related signals in energy homeostasis
- (2012) Andrew A. Young NEUROPHARMACOLOGY
- Localization of calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1) in human gastrointestinal tract
- (2012) Graeme S. Cottrell et al. PEPTIDES
- Critical role of calcitonin gene-related peptide receptors in cortical spreading depression
- (2012) A. Tozzi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
- (2011) David J Hewitt et al. CEPHALALGIA
- Excellent Tolerability But Relatively Low Initial Clinical Efficacy of Telcagepant in Migraine: A Response
- (2011) Tony W. Ho et al. HEADACHE
- Effect of Telcagepant on Spontaneous Ischemia in Cardiovascular Patients in a Randomized Study
- (2011) Martin O. Behm et al. HEADACHE
- Mapping the CGRP receptor ligand binding domain: Tryptophan-84 of RAMP1 is critical for agonist and antagonist binding
- (2010) E.L. Moore et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The potent calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men
- (2010) Bart J. Van der Schueren et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
- (2010) Hans-Christoph Diener et al. CEPHALALGIA
- Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
- (2010) Jakob Møller Hansen et al. CEPHALALGIA
- Long-Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial
- (2010) Kathryn M. Connor et al. HEADACHE
- Effect of Calcitonin Gene-Related Peptide Receptor Antagonism on the Systemic Blood Pressure Responses to Mechanistically Diverse Vasomodulators in Conscious Rats
- (2010) Joseph J Lynch et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Characterization of the Calcitonin Gene-Related Peptide Receptor Antagonist Telcagepant (MK-0974) in Human Isolated Coronary Arteries
- (2010) K. Y. Chan et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- CGRP and its receptors provide new insights into migraine pathophysiology
- (2010) Tony W. Ho et al. Nature Reviews Neurology
- A key role for tryptophan 84 in receptor activity-modifying protein 1 in the amylin 1 receptor
- (2010) Joseph J. Gingell et al. PEPTIDES
- Crystal Structure of the Ectodomain Complex of the CGRP Receptor, a Class-B GPCR, Reveals the Site of Drug Antagonism
- (2010) Ernst ter Haar et al. STRUCTURE
- Possible sites of action of the new calcitonin gene-related peptide receptor antagonists
- (2010) Sajedeh Eftekhari et al. Therapeutic Advances in Neurological Disorders
- Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974)
- (2009) Simon R. Sinclair et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of the prototype serotonin 5-HT1B/1D receptor agonist sumatriptan and the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP8–37 on myocardial reactive hyperemic response in conscious dogs
- (2009) Joseph J. Lynch et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Is there an inherent limit to acute migraine treatment efficacy?
- (2009) Marcelo E. Bigal et al. JOURNAL OF HEADACHE AND PAIN
- Randomized, controlled trial of telcagepant for the acute treatment of migraine
- (2009) K. M. Connor et al. NEUROLOGY
- Calcitonin Gene-Related Peptide8-37 Antagonizes Capsaicin-Induced Vasodilation in the Skin: Evaluation of a Human in Vivo Pharmacodynamic Model
- (2008) B. J. Van der Schueren et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Calcitonin Gene-Related Peptide Receptor Antagonism Does Not Affect the Severity of Myocardial Ischemia during Atrial Pacing in Dogs with Coronary Artery Stenosis
- (2008) C. P. Regan et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now